Which groundbreaking medical product took the shortest time from initial development to FDA approval, creating a new standard for accelerated development during a health crisis?

The medical industry constantly evolves through innovative product development. Major breakthroughs often come after extensive research, clinical trials, and regulatory hurdles. This poll tests your knowledge about a significant pharmaceutical development process that changed treatment paradigms. Understanding the journey from laboratory to patient care reveals the complex path medical innovations must travel before reaching those who need them most.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Moderna's COVID-19 mRNA vaccine (10 months from sequencing to emergency use authorization)
Merck's Ebola vaccine (4 years from initial trials to approval)
Gilead's remdesivir antiviral treatment (5 years from development to emergency use)
AstraZeneca's COVID-19 viral vector vaccine (14 months from development to first approvals)